Colorectal cancer in heart transplant recipients: A competing risk analysis
European Journal of Clinical Investigation · 2026
DOI: 10.1111/eci.70107 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Investigation, 2026. Verfasst von Alan Abboud und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Stony Brook University, Stony Brook, New York, USA. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Heart Transplantation, Postoperative Complications. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
Background
Data on colorectal cancer (CRC) risk in heart transplant (HT) patients are limited, and screening recommendations specific to this population, especially patients under age 45, are lacking. We aimed to assess the incidence of post‐HT CRC, with a focus on the effect of age.
Methods
Using data from the TriNetX Research Network, we identified 4516 adults (≥18 years) who received HT between 1996 and 2024 in the United States, based on CPT codes for HT (33945) and combined lung‐HT (33935). CRC was identified from ICD‐10 CM codes (C18, C19, & C20). Because mortality was higher than CRC risk, we used a competing risks framework to estimate CRC incidence.
Results
After a median follow‐up of 3.6 years (25th–75th percentile, 1.4–6.7), 48 patients developed CRC. Median time from HT to CRC was 4.5 years (.7–8.0). The cumulative incidence of CRC was 1.73% (CI: 1.22%–2.45%) at 10 years, corresponding to 173/100,000 person‐years. In comparison, the United States age‐adjusted general population rate was 36.5/100,000 between 2016 and 2020. Age at HT was not significantly associated with CRC risk ( p = .22); patients age < 45 at HT experienced similar risk as patients ≥45. The CRC risk difference between men and women was not significant (1.89% vs. 1.23% at 10 years; p = .74). All‐cause mortality was 20.4% at 5 years and 38.8% at 10 years.
Conclusions
In this HT cohort, CRC risk was markedly higher compared to the general population and did not differ by age, suggesting that HT recipients may require screening for CRC regardless of age.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Stony Brook University, Stony Brook, New York, USA.
- Baylor Scott & White Research Institute, Dallas, Texas, USA.
- Division of Gastroenterology, Department of Medicine, Stony Brook University, Stony Brook, New York, USA.
- Division of Cardiology, Department of Medicine, Stony Brook University, Stony Brook, New York, USA.
ORCID-Profile: Alan Abboud, Andreas Kalogeropoulos
Zitieren
APA
Abboud, A., Tajerian, A., Charles, S., Clores, M., Goldschmidt, M., Aroniadis, O., & Kalogeropoulos, A. (2026). Colorectal cancer in heart transplant recipients: A competing risk analysis. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.70107
Vancouver
Abboud A, Tajerian A, Charles S, Clores M, Goldschmidt M, Aroniadis O, et al. Colorectal cancer in heart transplant recipients: A competing risk analysis. European Journal of Clinical Investigation. 2026. doi:10.1111/eci.70107
BibTeX
@article{Abboud2026,
author = {Abboud, Alan and Tajerian, Amin and Charles, Sharon and Clores, Michael and Goldschmidt, Marc and Aroniadis, Olga and Kalogeropoulos, Andreas},
title = {Colorectal cancer in heart transplant recipients: A competing risk analysis},
journal = {European Journal of Clinical Investigation},
year = {2026},
doi = {10.1111/eci.70107}
}
EUVIMED